Case Report
Anti-SARS-CoV-2 Antibody Level among Renal Transplant Recipients: A Case Report from Nepal
Table 1
Different variables of the three renal transplant recipients.
| Clinical variables | Patient 1 | Patient 2 | Patient 3 |
| Age | 40 | 38 | 41 | Gender | Male | Male | Male | Transplant performed | 2008 | 2005 | 2006 | Current medications | Mycophenolate sodium 360 mg and tacrolimus 0.5 mg | Mycophenolate mofetil 500 mg and cyclosporine 25 mg | Mycophenolate mofetil 500 mg and tacrolimus (1 mg and 0.5 mg) | Body mass index | Overweight | Normal | Overweight | Comorbidities | No | No | Hypertension | 1st dose COVID vaccine | 16 April 2021 | 21 April 2021 | 01 June 2021 | 2nd dose COVID vaccine | 21 June 2021 | 08 June 2021 | 08 July 2021 | Serum creatinine (mg/dl) | 1.3 | 1.4 | 1.2 | Serum urea (mg/dl) | 41.0 | 16.96 | 21.0 | Sodium (Na+) mmol/l | 136 | 139.0 | 143.0 | Potassium (K+) mmol/l | 4.8 | 3.3 | 4.0 | Hemoglobin (g/dl) | 15.8 | 12.6 | 12.7 | RBC (million/mm3) | 5.48 | 4.64 | 4.76 | WBC (cells/mm3) | 7900 | 8400 | 12500 | Differential cell count | | | | Neutrophil (%) | 78 | 74 | 77 | Lymphocyte (%) | 16 | 21 | 21 | Monocyte (%) | 04 | 4 | 02 | Eosinophil (%) | 02 | 1 | 0 | Basophil (%) | 0 | 0 | 0 | RT-PCR for COVID-19 | Positive | Positive | Not tested | COVID-19 sign and symptoms | Fever, body ache, and loss of smell | Fever, malaise, sore throat, and loss of smell and taste | Unknown | Anti-SARS-CoV-2 ab (method) | 18.15 COI (ECLIA) | 54.5 (ELISA) | 5.91 U/ml (ECLIA) | Outcome | Recovered from COVID-19 | Recovered from COVID-19 | Stable |
|
|
Note. Morning dose; evening dose. NR: normal range; RT-PCR: reverse transcription polymerase chain reaction; ELISA: enzyme-linked immunosorbent assay; ECLIA: electrochemiluminescence immunoassay; ab: antibody; COI: cutoff index. |